Efficacy and safety of rivaroxaban in prevention and therapy of thromboembolic events in patients with nonvalvular atrial fibrillation
Context: Rivaroxaban is an oral direct factor Xa inhibitor reducing the risk of systemic embolism and stroke in patients with nonvalvular atrial fibrillation. Aims: The primary objective was to evaluate the effectiveness of rivaroxaban therapy in reducing the risk of systemic embolism and stroke in...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Serier: | Journal of the Practice of Cardiovascular Sciences |
| Fag: | |
| Online adgang: | http://www.j-pcs.org/article.asp?issn=2395-5414;year=2023;volume=9;issue=2;spage=110;epage=115;aulast=Preradovic |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|